|
Apr 1
|
Clinical Collaboration Agreement between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-’248) Respiratory Program; Teva and Abingworth Enter Strategic Development Funding Agreement
|
|
Mar 28
|
Bausch (BHC) Soars 6.4%: Is Further Upside Left in the Stock?
|
|
Mar 26
|
Institutional investors have a lot riding on Teva Pharmaceutical Industries Limited (NYSE:TEVA) with 67% ownership
|
|
Mar 25
|
Will Corcept (CORT) Bank on Korlym in 2024 Amid Stiff Rivalry?
|
|
Mar 24
|
25 Countries with the Lowest Fertility Rates
|
|
Mar 22
|
Q4 2023 Alvotech SA Earnings Call
|
|
Mar 21
|
GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US
|
|
Mar 19
|
AstraZeneca (AZN) Follows Boehringer, to Cap Inhaler Cost in US
|
|
Mar 18
|
Now That Two Inhaler Makers Are Capping Patient Costs, Will More Follow?
|
|
Mar 8
|
EVP, CFO Eliyahu Kalif Sells 77,550 Shares of Teva Pharmaceutical Industries Ltd (TEVA)
|
|
Feb 5
|
Chief Accounting Officer Amir Weiss Sells 31,766 Shares of Teva Pharmaceutical Industries Ltd
|
|
Feb 2
|
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Just Reported And Analysts Have Been Lifting Their Price Targets
|
|
Jan 12
|
Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology Space
|
|
Jan 10
|
3 No-Brainer Stocks to Buy With $20 Right Now
|
|
Jan 4
|
Biotech Stock Roundup: VYGR Gains From NVS Deal, AGIO Up on Study Data & More
|
|
Jan 2
|
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024
|
|
Jan 2
|
Corcept (CORT) Falls on Loss of Korlym Patent Lawsuit to Teva
|
|
Dec 29
|
Corcept loses patent spat against Teva, shares tumble
|
|
Dec 29
|
UPDATE 2-Corcept loses patent spat against Teva, shares tumble
|
|
Dec 28
|
Teva to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|